The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of zenocutuzumab in advanced pancreas cancer and other solid tumors harboring NRG1 fusions.
 
Alison M. Schram
Research Funding - AstraZeneca (Inst); BeiGene (Inst); Black Diamond Therapeutics (Inst); Kura Oncology (Inst); Lilly (Inst); Merus (Inst); Northern Biologics (Inst); Pfizer (Inst); Relay Therapeutics (Inst); Surface Oncology (Inst)
 
Eileen Mary O'Reilly
Consulting or Advisory Role - Agios (I); AstraZeneca (I); Autem Medical (I); Bayer (I); BeiGene (I); Berry Genomics (I); Celgene (I); CytomX Therapeutics; Debiopharm Group (I); Eisai (I); Exelixis/Ipsen (I); Flatiron Health (I); Genentech/Roche (I); Gilead Sciences (I); Incyte (I); Ipsen (I); Janssen; LAM Therapeutics (I); Lilly (I); Loxo; Merck; Minapharma (I); QED Therapeutics (I); RedHill Biopharma (I); Silenseed; Sillajen (I); SOBI; TheraBionic (I); twoXAR; Vector Health (I); Yiviva (I)
Research Funding - Acta Biologica (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech (Inst); Halozyme (Inst); MabVax (Inst); Roche (Inst); Silenseed (Inst)
 
Grainne M. O'Kane
Honoraria - AstraZeneca; Eisai; Roche
Consulting or Advisory Role - Eisai; Roche
Travel, Accommodations, Expenses - AstraZeneca/MedImmune
 
Koichi Goto
Honoraria - Amgen; AstraZeneca Japan; Boehringer Ingelheim; Bristol-Myers Squibb K.K.; Chugai Pharma; DAIICHI SANKYO Co., Ltd.; Eisai; Guardant Health; Janssen; Kyowa Kirin Co., Ltd.; Life Technologies; Lilly Japan; MSD K.K.; Nippon Kayaku; Novartis; Ono Pharmaceutical; Otsuka; Pfizer; Taiho Pharmaceutical; Takeda
Consulting or Advisory Role - Otsuka
Research Funding - Amgen; Amgen Astellas BioPharma; Astellas Pharma; AstraZeneca Japan; Boehringer Ingelheim; Bristol-Myers Squibb K.K.; Chugai Pharma; Eisai; Ignyta; Janssen; Kissei Pharmaceutical; Kyowa Kirin Co., Ltd.; Life Technologies; Lilly Japan; Loxo; MEDICAL & BIOLOGICAL LABORATORIES CO., LTD.; Merck; Merus; MSD K.K.; NEC Corporation; Ono Pharmaceutical; Pfizer; Shanghai HaiHe Pharmaceutical; Spectrum Pharmaceuticals; Sumitomo Dainippon Pharma Co., Ltd.; Sysmex; Taiho Pharmaceutical; Takeda; Xcoo
 
Dong-Wan Kim
Research Funding - Alpha Biopharma (Inst); Amgen (Inst); AstraZeneca/MedImmune (Inst); Boehringer Ingelheim (Inst); Daiichi Sankyo (Inst); Hanmi (Inst); Janssen (Inst); Merus (Inst); Mirati Therapeutics (Inst); MSD (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Roche/Genentech (Inst); Takeda (Inst); TP Therapeutics (Inst); Xcovery (Inst); Yuhan (Inst)
Travel, Accommodations, Expenses - Amgen; Daiichi Sankyo
 
Cindy Neuzillet
Honoraria - Amgen; AstraZeneca; Baxter; Bristol-Myers Squibb; Fresenius Kabi; Incyte; Merck; MSD Oncology; Mylan; Novartis; Nutricia; Pierre Fabre; Roche; SERVIER
Research Funding - AstraZeneca (Inst); OSE Immunotherapeutics (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Amgen; Merck; MSD Oncology; Mylan; OSE Immunotherapeutics
 
Patricia Martin-Romano
Honoraria - Ability Pharma; Roche
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Roche
 
Michaël Duruisseaux
Consulting or Advisory Role - Abbvie; Amgen; Amgen; AstraZeneca; BMS; Boehringer Ingelheim; Janssen Oncology; MSD Oncology; Pfizer; Roche; Takeda
Travel, Accommodations, Expenses - Boehringer Ingelheim; MSD
 
Misako Nagasaka
Consulting or Advisory Role - AstraZeneca; Caris Life Sciences; Daiichi Sankyo; EMD Serono; Novartis; Takeda
Speakers' Bureau - Blueprint Medicines
Research Funding - Tempus
Travel, Accommodations, Expenses - Anheart Therapeutics
 
Jordi Rodon
Consulting or Advisory Role - Bayer; Certara Inc; Ellipses Pharma; Kelun Pharmaceuticals/Klus Pharma; Lilly; Merck Sharp & Dohme; Molecular Partners; Novartis; NovellusDx; Orion; Peptomyc; Pfizer; Roche; SERVIER; Spectrum Pharmaceuticals
Research Funding - Bayer (Inst); BioAtla (I); Blueprint Medicines (Inst); CytomX Therapeutics (Inst); Genmab (Inst); GlaxoSmithKline (Inst); Ipsen (Inst); Kelun (Inst); Novartis (Inst); Pfizer (Inst); Spectrum Pharmaceuticals (Inst); Symphogen (Inst); Takeda/Millennium (Inst); Tocagen (Inst)
Travel, Accommodations, Expenses - Bayer; Cancer Core Europe; Department of Defense-Prostate Cancer Research Program; ESMO; Huntsman Cancer Institute; Janssen; Karolinska Cancer Institute; Kelun Pharmaceuticals/Klus Pharma; King Abdullah International Medical Research Center; Louisiana State University; Merck Sharp & Dohme; Molecular Partners; WIN Consortium
Other Relationship - Chinese University of Hong Kong; Elsevier; European Journal of Cancer; GlaxoSmithKline; SOLTI; VHIO/Ministero De Empleo Y Seguridad Social
 
Benjamin Adam Weinberg
Employment - Apple (I)
Stock and Other Ownership Interests - Apple (I)
Honoraria - Rafael Pharmaceuticals
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; Bayer; HalioDx
Speakers' Bureau - AstraZeneca; Bayer; Diiachi Sankyo; HalioDx; Lilly; Sirtex Medical; Taiho Pharmaceutical
Research Funding - Abbvie (Inst); Ipsen (Inst); Isofol Medical (Inst); Novartis (Inst)
Expert Testimony - AstraZeneca
Travel, Accommodations, Expenses - Boehringer Ingelheim; Caris Life Sciences
 
Kumiko Umemoto
Honoraria - Taiho Pharmaceutical
 
Sai-Hong Ignatius Ou
Stock and Other Ownership Interests - Elevation Oncology; Turning Point Therapeutics
Honoraria - ARIAD/Takeda; AstraZeneca; Genentech/Roche; Pfizer; Roche Pharma AG
Consulting or Advisory Role - AstraZeneca; Janssen; Pfizer; Roche/Genentech; Takeda
Speakers' Bureau - AstraZeneca; Genentech/Roche
Research Funding - ARIAD (Inst); AstraZeneca (Inst); AstraZeneca/MedImmune (Inst); Janssen (Inst); Mirati Therapeutics (Inst); Pfizer (Inst); Revolution Medicines (Inst); Roche Pharma AG (Inst)
 
Teresa Macarulla
Consulting or Advisory Role - AstraZeneca; Baxalta; Baxter; Celgene; Eisai; Genzyme; Incyte; Ipsen; Lilly; Menarini; MSD; Polaris; Prime Oncology; QED Therapeutics; Roche; Sanofi/Aventis; SERVIER; Shire; Surface Oncology
Research Funding - Agios (Inst); ASLAN Pharmaceuticals (Inst); AstraZeneca (Inst); Bayer (Inst); Celgene (Inst); Genentech (Inst); Halozyme (Inst); Immunomedics (Inst); Lilly (Inst); Merrimack (Inst); Millennium (Inst); Novartis (Inst); Novocure (Inst); Pfizer (Inst); Pharmacyclics (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Celgene; H3 Biomedicine; Merck; Sanofi; SERVIER
 
Christelle De La Fouchardiere
Honoraria - Merck Serono; Merck Serono; Roche; Roche
Consulting or Advisory Role - Amgen; Amgen; Bayer; Bristol-Myers Squibb; Lilly; Pierre Fabre; Roche; SERVIER
Research Funding - Roche
Travel, Accommodations, Expenses - Amgen; Amgen; Bristol-Myers Squibb; Celgene; Roche; Roche; SERVIER
Other Relationship - Incyte; MSD Oncology
 
Andrew K. Joe
Employment - Merus NV; Sanofi
Leadership - Merus NV
Stock and Other Ownership Interests - Merck Sharp & Dohme; Merus NV; Sanofi
Travel, Accommodations, Expenses - Merus NV; Sanofi
 
Ernesto Wasserman
Employment - Merus
Stock and Other Ownership Interests - Merus
 
Viktoriya Stalbovskaya
Employment - Merus NV
Stock and Other Ownership Interests - Merus NV
Travel, Accommodations, Expenses - Merus NV
 
Jim Ford
Employment - Merus
Stock and Other Ownership Interests - Merus
 
Alexander Drilon
Honoraria - Foundation Medicine; Medscape; MORE Health; OncLive; Peerview; PeerVoice; Physicans' Education Resource; Research to Practice; Targeted Oncology
Consulting or Advisory Role - 14ner Oncology/Elevation Oncology; Abbvie; Archer; AstraZeneca; Bayer; BeiGene; BerGenBio; Blueprint Medicines; EMD Serono/Merck; Exelixis; Genentech/Roche; Helsinn Therapeutics; Hengrui Therapeutics; Ignyta; Lilly; Loxo; Melendi; Monopteros Therapeutics; Monopteros Therapeutics; MORE Health; Novartis; Pfizer; Remedica; Repare Therapeutics; Takeda/Millennium; TP Therapeutics; Tyra Biosciences; Verastem; Verastem
Research Funding - Foundation Medicine
Patents, Royalties, Other Intellectual Property - Wolters Kluwer (Royalties for Pocket Oncology)
Other Relationship - GlaxoSmithKline; Merck; Pfizer; PharmaMar; Puma Biotechnology; Taiho Pharmaceutical; Teva